Rosely Yamamura

Medical Oncologist. Clinical Research Physician.
#ClinicalResearch

[Rosely Yamamura @RoselyYamamura]

@PrimeVideoBR Happy Birthday, Jiminnnnnnn!!! 💜🎂💜😇💜

[IASLC @IASLC]

A simple low-dose CT scan can find lung cancer early—when it’s easier to treat and more likely to be cured. RT to share! https://t.co/12y36xksCe #LCAM #LCSM

[Vivek Subbiah, MD @VivekSubbiah]

Great that #cell published our At-a-glance Snapshot: Trial Types in #PrecisionMedicine @CellPressNews @DaneJDicksonMD @CellCellPress https://t.co/SyWocuAgLI

[IASLC @IASLC]

We are excited to share with you the preliminary program for the IASLC WCLC 2020: Virtual Presidential Symposium on August 8, 2020. Registration for this exclusive event is complimentary.

#IASLC #LungCancerResearch #IASLCWCLC2020

https://t.co/aCTlqMVfiS

[Mara Antonoff, MD, FACS @maraantonoff]

Asymptomatic cancer survivor comes in for surveillance cancer screening imaging. CT shows bilateral ground glass findings, so COVID test is ordered—and positive. Incidental findings such as this suggest frightening limitations in our awareness of infection rates.

[MOC Brasil @MOCBrasil]

Inscrições abertas | Programa de Fellowship em Cancerologia Clínica 2020 da BP

Acesse o site para maiores informações:
https://t.co/OSKUSOVvjj

@bporgbr @RoselyYamamura @camillayamada @rcarvalhoonco @thiagoonco @DGagliato @FabioSchutz78 @scheinbp @MelanomaSarcoma

[BJ Miller @bjmillermd]

Profound, meet mundane. Mundane, profound.
https://t.co/dGMqJ3NqSh

[MOC Brasil @MOCBrasil]

III Simpósio de Câncer de Pulmão
- com Dr Daniel Costa, Dr Hisao Asamura, Dr Keith Kerr e Dra Paula Ugalde

06 e 07 Dezembro de 2019
Hotel Pullman Vila Olímpia - São Paulo-SP

Participe!

#LCSM #lungcancer @CarolinaKHaddad @RoselyYamamura https://t.co/QNOkoTx6TZ

[Rosely Yamamura @RoselyYamamura]

Cerimônia de encerramento! 🤩
#ppcr2019

[Invitare Comunicação @Invitare2015]

Estão abertas!!!!!!
Corre lá!

Cursos de Formação e Capacitação em Pesquisa Clínica 2020 já estão com inscrições abertas!

https://t.co/cT7P6tZjbN
(11) 5581-1019

#pesquisaclínica #curso #formação #capacitação #cursos #pesquisa #clínica #cep

[IASLC @IASLC]

IASLC #WCLC19 Press Release: "Durvalumab combined with chemotherapy improves overall survival in patients with extensive lung stage cancer; First-line treatment reduces mortality risk by 27 percent." #LCSM https://t.co/97YJGlTDff

[UroToday.com @urotoday]

#APCCC19 presentation slides available now for download. Visit UroToday, email address requested at the top of the screen prior to access! https://t.co/4z37gdHDjg @apccc19 @pezaro_c @Prof_IanD @DrYukselUrun @Tiahigano @sgkssg
@DrMHofman @Prof_Nick_James @WilliamOhMD

[Rosely Yamamura @RoselyYamamura]

Critical thinking: essential for every physician!
#ASCO19 #MOCnaASCO

[Rosely Yamamura @RoselyYamamura]

Hello! I’m a Medical Oncologist from Brazil! First LCSM Chat 🙂! #lcsm

[Rosely Yamamura @RoselyYamamura]

Excelente oportunidade para aprimorar o conhecimento!!!

[MOC Brasil @MOCBrasil]

Programa de Fellowship em Cancerologia Clínica – Oportunidade!

Ainda dá tempo de inscrever-se no processo seletivo de Fellowship em Oncologia Clínica da BP – A Beneficência Portuguesa de São Paulo e atuar ao lado de oncologistas clínicos renomados.... https://t.co/CVoyCZjBdi

[MOC Brasil @MOCBrasil]

[Oportunidade] Estão abertas as inscrições para o programa de Fellowship em Oncologia Clínica da BP – A Beneficência Portuguesa de São Paulo

Para acessar o edital e saber mais sobre o programa, acesse:... https://t.co/jKdeCBeO9U

[Rosely Yamamura @RoselyYamamura]

💡 FELLOWSHIP EM CANCEROLOGIA CLÍNICA 2019 💡
BP - A Beneficência Portuguesa de São Paulo @bporgbr

Informações e inscrições:
https://t.co/8PyRc0m15K

[JTO & JTO CRR @JTOonline]

Happy New Year! To start off 2019, we've published an article by @suresh_lab, @DrJNaidoo and others: "Impact of Checkpoint Inhibitor Pneumonitis on Survival in #NSCLC Patients Receiving Immune Checkpoint Immunotherapy." #LCSM

Read the full article --> https://t.co/JzaGA3R1HP.

[Shahrokh F. Shariat @DrShariat]

We found that patients treated with external beam radiotherapy are at an increased risk of developing a second primary bladder cancer tumor compared to radical prostatectomy patients. https://t.co/Wac2aGAHSq

[The ROS1ders, Inc. @ros1cancer]

Targeted therapy should come before immunotherapy for #lungcancer driven by #ROS1, #ALK, #EGFR, and #MET alterations. "A Cautionary Analysis of Immunotherapy Prior to Targeted Therapy" https://t.co/jfw8sUc4vH #LCSM @EGFRResisters @ALKLungCancer